Skip to main content
HR 437 103th Congress House Health Abortion Cancer Cancer research Clinical trials Contraceptives Drugs Endometrial cancer Peer review organizations (Medicine) Pharmaceutical research

Antiprogestin Testing Act of 1993

Introduced: January 5, 1993 Introduced by: Wyden, Ron Democratic · Oregon See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 3, 1993
Referred to the Subcommittee on Health and the Environment.
Jan 5, 1993
Referred to the House Committee on Energy and Commerce.
Jan 5, 1993
Introduced in House
 Plain-English summary Congressional Research Service

Antiprogestin Testing Act of 1993 - Directs the Secretary of Health and Human Services to conduct and support research, including clinical trials, on antiprogestin drug safety and efficacy for any potential use, including termination of pregnancy, contraception, and therapeutic use for cancer, endocrine disorders, and endometriosis. Makes the research subject to provisions of the Public Health Service Act relating to institutional review boards and peer review.

What's happening now February 3, 1993

Referred to the Subcommittee on Health and the Environment.

 Committees of jurisdiction 2